pBAD-BirA-eCPX-AP(K10)
(Plasmid
#121908)
-
PurposeExpresses BirA and eCPX-AP(K10)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 121908 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBAD
- Backbone size w/o insert (bp) 4000
- Total vector size (bp) 5919
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert 1
-
Gene/Insert nameBirA
-
SpeciesSynthetic
-
Insert Size (bp)984
-
Entrez GenebirA (a.k.a. b3973, ECK3965, bioR, dhbB)
- Promoter pBAD promoter
-
Tag
/ Fusion Protein
- 6xHis (C terminal on insert)
Cloning Information for Gene/Insert 1
- Cloning method Ligation Independent Cloning
- 5′ sequencing primer pBAD (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert nameenhanced Circularly Permuted Outer Membrane Protein X
-
Alt nameeCPX
-
SpeciesSynthetic
-
Insert Size (bp)627
-
Mutationchanged lysine 10 in the AP to alanine
- Promoter T7
Cloning Information for Gene/Insert 2
- Cloning method Ligation Independent Cloning
- 5′ sequencing primer T7 (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBAD-BirA-eCPX-AP(K10) was a gift from Per Svenningsen (Addgene plasmid # 121908 ; http://n2t.net/addgene:121908 ; RRID:Addgene_121908) -
For your References section:
A bacterial display system for effective selection of protein-biotin ligase BirA variants with novel peptide specificity. Granhoj J, Dimke H, Svenningsen P. Sci Rep. 2019 Mar 11;9(1):4118. doi: 10.1038/s41598-019-40984-x. 10.1038/s41598-019-40984-x PubMed 30858523